Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications, Newcastle Disease Virus /von 2019-12-10 / Br. J. Cancer 2020 Jan;122(1):111-120Evaluation of Newcastle disease virus mediated dendritic cell activation and cross-priming tumor-specific immune responses ex vivo
/in Breast Cancer, Dendritic Cells, International Publications, Newcastle Disease Virus /von 2019-11-01 / Int J Cancer 2020 01;146(2):531-541Evaluation of a Recombinant Newcastle Disease Virus Expressing Human IL12 against Human Breast Cancer
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2019-09-30 / Sci Rep 2019 Sep;9(1):139992-Deoxyglucose and Newcastle Disease Virus Synergize to Kill Breast Cancer Cells by Inhibition of Glycolysis Pathway Through Glyceraldehyde3-Phosphate Downregulation
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2019-09-27 / Front Mol Biosci 2019;6:90Past, Current, and Future of Immunotherapies for Prostate Cancer
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Newcastle Disease Virus, Prostate Cancer /von 2019-09-11 / Front Oncol 2019;9:884The current state of immunotherapy for gliomas: an eye toward the future
/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease Virus /von 2019-09-01 / J. Neurosurg. 2019 09;131(3):657-666Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2019-08-30 / Biomedicines 2019 Aug;7(3)Application of Newcastle disease virus in the treatment of colorectal cancer
/in Colorectal Cancer, International Publications, Newcastle Disease Virus /von 2019-08-26 / World J Clin Cases 2019 Aug;7(16):2143-2154Possible viral oncolysis by members of the Reoviridae and Paramyxoviridae families (an in vitro study).
/in International Publications, Newcastle Disease Virus /von 2019-05-31 / J Clin Oncol 37, 2019 (suppl; abstr e14212)IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution